Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Carducci

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Acta Dermato-Venereologica|March 14, 1998
Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severityC Bonifati, A Mussi, M Carducci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancerD Kaufman, D Raghavan, M Carducci, et al.
Archives of Dermatological Research|June 1, 1997
Interleukin-11 production is increased in organ cultures of lesional skin of patients with active plaque-type psoriasis as compared with nonlesional and normal skin. Similarity to interleukin-1 beta, interleukin-6 and interleukin-8F Ameglio, C Bonifati, M Fazio, et al.
Cancer Gene Therapy|January 10, 2002
A novel method for the determination of basal gene expression of tissue-specific promoters: an analysis of prostate-specific promotersH G van der Poel, J McCadden, G W Verhaegh, et al.
British Journal of Cancer|April 27, 2016
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumoursD Mahalingam, G Wilding, S Denmeade, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 30, 2021
Debridement, antibiotics and implant retention (DAIR): An effective treatment option for early prosthetic joint infectionsP Tatarelli, T Romani, V Santoro, et al.
Behavioural Brain Research|March 25, 2014
Impaired sensorimotor gating in Fmr1 knock out and Fragile X premutation model miceA J Renoux, K J Sala-Hamrick, N M Carducci, et al.
Urology|May 30, 2001
Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomyW W Roberts, E J Bergstralh, M L Blute, et al.
The AAPS Journal|June 27, 2025
Dissolution of Oral Solid Dosage Formulations: Surrogate Models and Real-time ReleaseMelanie Dumarey, Tessa M Carducci, Matthew J Walworth, et al.
Cancer Treatment and Research Communications|July 13, 2019
Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421P N Lara, M Plets, C Tangen, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Acta Dermato-Venereologica|March 14, 1998
Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severityC Bonifati, A Mussi, M Carducci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancerD Kaufman, D Raghavan, M Carducci, et al.
Archives of Dermatological Research|June 1, 1997
Interleukin-11 production is increased in organ cultures of lesional skin of patients with active plaque-type psoriasis as compared with nonlesional and normal skin. Similarity to interleukin-1 beta, interleukin-6 and interleukin-8F Ameglio, C Bonifati, M Fazio, et al.
Cancer Gene Therapy|January 10, 2002
A novel method for the determination of basal gene expression of tissue-specific promoters: an analysis of prostate-specific promotersH G van der Poel, J McCadden, G W Verhaegh, et al.
British Journal of Cancer|April 27, 2016
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumoursD Mahalingam, G Wilding, S Denmeade, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 30, 2021
Debridement, antibiotics and implant retention (DAIR): An effective treatment option for early prosthetic joint infectionsP Tatarelli, T Romani, V Santoro, et al.
Behavioural Brain Research|March 25, 2014
Impaired sensorimotor gating in Fmr1 knock out and Fragile X premutation model miceA J Renoux, K J Sala-Hamrick, N M Carducci, et al.
Urology|May 30, 2001
Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomyW W Roberts, E J Bergstralh, M L Blute, et al.
The AAPS Journal|June 27, 2025
Dissolution of Oral Solid Dosage Formulations: Surrogate Models and Real-time ReleaseMelanie Dumarey, Tessa M Carducci, Matthew J Walworth, et al.
Cancer Treatment and Research Communications|July 13, 2019
Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421P N Lara, M Plets, C Tangen, et al.
Pageof 7